Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis

Federico Oldoni, Damiano Baldassarre, Samuela Castelnuovo, Alice Ossoli, Mauro Amato, Julian van Capelleveen, G. Kees Hovingh, Eric de Groot, Andrea Bochem, Sara Simonelli, Simone Barbieri, Fabrizio Veglia, Guido Franceschini, Jan Albert Kuivenhoven, Adriaan G. Holleboom, Laura Calabresi

Research output: Contribution to journalArticleAcademicpeer-review

52 Citations (Scopus)

Abstract

BACKGROUND: Lecithin:cholesterol acyltransferase (LCAT) is the sole enzyme that esterifies cholesterol in plasma. Its role in the supposed protection from atherogenesis remains unclear because mutations in LCAT causing fish-eye disease (FED) or familial LCAT deficiency (FLD) have been reported to be associated with more or instead less carotid atherosclerosis, respectively. This discrepancy may be associated with the loss of cholesterol esterification on only apolipoprotein AI (FED) or on both apolipoprotein AI- and apolipoprotein B-containing lipoproteins (FLD), an aspect that has thus far not been investigated.
Original languageEnglish
Pages (from-to)1000-1007
JournalCirculation
Volume138
Issue number10
DOIs
Publication statusPublished - 2018

Cite this